Yıl: 2014 Cilt: 14 Sayı: 2 Sayfa Aralığı: 106 - 114 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta

Öz:
Objective: This study aimed to evaluate the serum gamma-glutamyltransferase (GGT) levels as an indirect marker of elevated oxidative stress in patients with dilated ascending aorta. Methods: The study was designed as an observational cross-sectional controlled study. One hundred consecutive patients with dilated ascending aorta and 50 consecutive controls with normal ascending aorta diameter were selected for the study by comprehensive transtho- racic echocardiography (TTE). The aortic dilatation group was divided into two subgroups, according to the literature as the ectasia group (3.8-4.3 cm, 53 patients, 24 male and 29 female, mean age: 62.9±10.9 years) and the aneurysm group (&#8805;4.4 cm, 47 patients, 18 male and 29 female, mean age: 65.5±11.1 years). The control group consisted of patients demonstrating no ascending aorta dilatation (&#8804;3.7 cm, 50 patients, 24 male and 26 female, mean age: 62.7±9.2 years). ANOVA, Mann-Whitney U test, Pearson&#8217;s correlation analysis, multivariate logistic regression analy- sis, and receiver-operator curve analysis were used for statistical analysis. Results: Regarding the comparison of laboratory parameters between the patient and control groups, serum gamma-glutamyltransferase (GGT) levels were found to be statistically significantly higher in both of the aortic dilatation subgroups than in the control group (p<0.001). In the cor- relation analysis between the ascending aorta diameter and GGT, a statistically significant positive correlation was found (r=0.282, p<0.001). The multivariate regression analysis revealed a significant relationship between GGT and the proximal ascending aorta diameter (&#946;=0.131, odds ratio: 1.140, 95% CI: 1.060-1.225, p<0.001). Conclusion: GGT as a marker of oxidative stress may play a role in the pathogenesis of aneurysm of the ascending aorta. (Anadolu Kardiyol Derg 2014; 14: 106-14)
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol 2010; 55: 27-129. [CrossRef]
  • 2. Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol 2010; 55: 841-57. [CrossRef]
  • 3. Kirsch, EW, Radu NC, Allaire E, Loisance DY. Pathobiology of idiopathic ascending aorta aneurysms. Asian Cardiovasc Thorac Ann 2006; 14: 254-60. [CrossRef]
  • 4. Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg 1984; 119: 405-9. [CrossRef]
  • 5. Elefteriades JA. Natural history of thoracic aorta aneurysms: indications for surgery and surgical versus nonsurgical risks. Ann Thorac Surg 2002; 74: 1877-80. [CrossRef]
  • 6. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aorta aneurysms. Arterioscler Thromb 1991; 11: 1667-77. [CrossRef]
  • 7. Harrison SC, Smith AJ, Jones GT, Swerdlow DI, Rampuri R, Bown MJ, et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J 2012 Oct 30. [Epub ahead of print]
  • 8. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, Hunter GC. Antioxidant enzyme activity in human abdominal aortaic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1999; 220: 39-45. [CrossRef]
  • 9. Zhang J, Schmidt J, Ryschich E, Mueller-Schilling M, Schumacher H, Allenberg JR. Inducible nitric oxide synthase is present in human abdominal aortaic aneurysm and promotes oxidative vascular injury. J Vasc Surg 2003; 38: 360-7. [CrossRef]
  • 10. Esen AM, Akçakoyun M, Esen O, Acar G, Emiroğlu Y, Pala S, et al. Uric acid as a marker of oxidative stress in dilatation of the ascending aorta. Am J Hypertens 2011; 24: 149-54. [CrossRef]
  • 11. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16: 534-54. [CrossRef]
  • 12. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535-9. [CrossRef]
  • 13. Ruttmann E, Brandt LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112: 2130-7. [CrossRef]
  • 14. Bozbaş H, Yıldırır A, Karaçağlar E, Demir O, Ulus T, Eroğlu S, et al. Increased serum gamma-glutamyltransferase activity in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2011; 39: 122-8. [CrossRef]
  • 15. Nakanishi N, Nishina K, Li W, Sato M, Suzuji K, Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle aged Japanese men. J Intern Med 2003; 254: 287-95. [CrossRef]
  • 16. Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Geleris P Boudoulas , H. Segmental analysis of the ascending aorta: definition of normality and classification of aortaic dilatation. J Cardiol 1989; 19: 945-53.
  • 17. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
  • 18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
  • 19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83. [CrossRef]
  • 20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63. [CrossRef]
  • 21. Lavall D, Schäfers HJ, Böhm M, Laufs U. Aneurysms of the ascending aorta. Dtsch Arztebl Int 2012; 109: 227-33.
  • 22. Cozijnsen L, Braam RL, Waalewijn RA, Schepens MA, Loeys BL, van Oosterhout MF, et al. What is new in dilatation of the ascending aorta ? Review of current literature and practical advice for the cardiologist. Circulation 2011; 123: 924-8. [CrossRef]
  • 23. Downing SW, Kouchoukos NT. Ascending aorta aneurysm. In: L. Henry Edmunds, ed. Cardiac Surgery in the Adult. New York: Mc Graw-Hill, 1997.p.1165-95.
  • 24. Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M, Rizzo JA, et al. Familial thoracic aorta aneurysms and dissections: incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006; 82: 1400-5. [CrossRef]
  • 25. Phillippi JA, Klyachko EA, Kenny JP 4th, Eskay MA, Gorman RC, Gleason TG. Basal and oxidative stress-induced expression of metallothionein is decreased in ascending aortic aneurysms of bicuspid aortaic valve patients. Circulation 2009; 119: 2498-506. [CrossRef]
  • 26. Brenneisen P Briviba K, Wlaschek M, Wenk J, Scharffetter- , Kochanek K. Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic Biol Med 1997; 22: 515-24. [CrossRef]
  • 27. Galis ZS, Asanuma K, Godin D, Meng X. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation 1998; 97: 2445-53. [CrossRef]
  • 28. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase- derived reactive oxygen species. Circ Res 2003; 92: 80-6. [CrossRef]
  • 29. Brenneisen P Briviba K, Wlaschek M, Wenk J, Scharffetter- , Kochanek K. Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic Biol Med 1997; 22: 515-24. [CrossRef]
  • 30. McCormick ML, Gavrila D, Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aorta aneurysms. Arterioscler Thromb Vasc Biol 2007; 27: 461-9. [CrossRef]
  • 31. Doroshow JH. Glutathione cycling in oxidative stress. Toxicol Lett 1995; 82-85: 395-8. [CrossRef]
  • 32. Kappus H, Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 1981; 37: 1233-41. [CrossRef]
  • 33. Mason JE, Starke RD, Van Kirk JE. .Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010; 13: 36-41. [CrossRef]
  • 34. Lee LC, Torres MC, Khoo SM, Chong EY, Lau C, Than Y, et al. The relative impact of obstructive sleep apnea and hypertension on the structural and functional changes of the thoracic aorta. Sleep 2010; 33: 1173-6.
  • 35. Kim NH, Huh JK, Kim BJ, Kim MW, Kim BS, Kang JH. Serum gamma-glutamyl transferase level is an independent predictor of incident hypertension in Korean adults. Clin Exp Hypertens 2012; 34: 402-9. [CrossRef]
  • 36. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovasc Diabetol 2010: 9: 87. [CrossRef]
  • 37. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. Gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007; 53: 71-7. [CrossRef]
  • 38. Lu H, Rateri DL, Cassis LA, Daugherty A. The role of the renin- angiotensin system in aortaic aneurysmal diseases. Curr Hypertens Rep 2008; 10: 99-106. [CrossRef]
  • 39. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: Triggering oxidative stress within the plaque. Circulation 2005; 112: 2078-80. [CrossRef]
  • 40. Drozdz R, Parmentier C, Hachad H, Leroy P Siest G, Wellman M. , Gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/ transferrin system. Free Radic Biol Med 1998; 25: 786-92. [CrossRef]
  • 41. Paolicchi A, Minotti G, Tonarelli P Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis. J Invest Med 1999; 47: 151-60.
  • 42. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004; 555: 589-606. [CrossRef]
  • 43. Tsukimori K, Yoshitomi T, Morokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens 2008; 21: 1343-6. [CrossRef]
  • 44. Jia SD, Wang YG, Li HF, Li J, Wang HY. Oxidative stress and endothelial dysfunction at different serum uric acid levels. Zhonghua Nei Ke Za Zhi 2008; 47: 638-41.
  • 45. Yiğiner Ö, Özçelik F, Aparcı M, Işılak Z, Uz O. The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ the effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. Anadolu Kardiyol Derg 2010; 10: 294-6. [CrossRef]
  • 46. Patetesios P Rodino W, Wisselink W, Bryan D, John D, Kırwin JD, et al. The abdominal aortic aneurysm: Genetics, pathophysiology, and molecular biology. Ann NY Acad Sci 2006; 1085: 1-408.
APA Demir B, ÇAĞLAR İ, TÜRELİ OKTAY H, ÖZDE C, AÇIKSARI G, Çiftçi S, ÜNGAN İ, Demir E, KARAKAYA O, Özyazgan S (2014). Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. , 106 - 114.
Chicago Demir Bulent,ÇAĞLAR İlker Murat,TÜRELİ OKTAY Hande,ÖZDE CEM,AÇIKSARI Gönül,Çiftçi Serkan,ÜNGAN İsmail,Demir Esra,KARAKAYA Osman,Özyazgan Sibel Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. (2014): 106 - 114.
MLA Demir Bulent,ÇAĞLAR İlker Murat,TÜRELİ OKTAY Hande,ÖZDE CEM,AÇIKSARI Gönül,Çiftçi Serkan,ÜNGAN İsmail,Demir Esra,KARAKAYA Osman,Özyazgan Sibel Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. , 2014, ss.106 - 114.
AMA Demir B,ÇAĞLAR İ,TÜRELİ OKTAY H,ÖZDE C,AÇIKSARI G,Çiftçi S,ÜNGAN İ,Demir E,KARAKAYA O,Özyazgan S Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. . 2014; 106 - 114.
Vancouver Demir B,ÇAĞLAR İ,TÜRELİ OKTAY H,ÖZDE C,AÇIKSARI G,Çiftçi S,ÜNGAN İ,Demir E,KARAKAYA O,Özyazgan S Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. . 2014; 106 - 114.
IEEE Demir B,ÇAĞLAR İ,TÜRELİ OKTAY H,ÖZDE C,AÇIKSARI G,Çiftçi S,ÜNGAN İ,Demir E,KARAKAYA O,Özyazgan S "Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta." , ss.106 - 114, 2014.
ISNAD Demir, Bulent vd. "Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta". (2014), 106-114.
APA Demir B, ÇAĞLAR İ, TÜRELİ OKTAY H, ÖZDE C, AÇIKSARI G, Çiftçi S, ÜNGAN İ, Demir E, KARAKAYA O, Özyazgan S (2014). Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. Anadolu Kardiyoloji Dergisi, 14(2), 106 - 114.
Chicago Demir Bulent,ÇAĞLAR İlker Murat,TÜRELİ OKTAY Hande,ÖZDE CEM,AÇIKSARI Gönül,Çiftçi Serkan,ÜNGAN İsmail,Demir Esra,KARAKAYA Osman,Özyazgan Sibel Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. Anadolu Kardiyoloji Dergisi 14, no.2 (2014): 106 - 114.
MLA Demir Bulent,ÇAĞLAR İlker Murat,TÜRELİ OKTAY Hande,ÖZDE CEM,AÇIKSARI Gönül,Çiftçi Serkan,ÜNGAN İsmail,Demir Esra,KARAKAYA Osman,Özyazgan Sibel Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. Anadolu Kardiyoloji Dergisi, vol.14, no.2, 2014, ss.106 - 114.
AMA Demir B,ÇAĞLAR İ,TÜRELİ OKTAY H,ÖZDE C,AÇIKSARI G,Çiftçi S,ÜNGAN İ,Demir E,KARAKAYA O,Özyazgan S Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. Anadolu Kardiyoloji Dergisi. 2014; 14(2): 106 - 114.
Vancouver Demir B,ÇAĞLAR İ,TÜRELİ OKTAY H,ÖZDE C,AÇIKSARI G,Çiftçi S,ÜNGAN İ,Demir E,KARAKAYA O,Özyazgan S Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. Anadolu Kardiyoloji Dergisi. 2014; 14(2): 106 - 114.
IEEE Demir B,ÇAĞLAR İ,TÜRELİ OKTAY H,ÖZDE C,AÇIKSARI G,Çiftçi S,ÜNGAN İ,Demir E,KARAKAYA O,Özyazgan S "Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta." Anadolu Kardiyoloji Dergisi, 14, ss.106 - 114, 2014.
ISNAD Demir, Bulent vd. "Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta". Anadolu Kardiyoloji Dergisi 14/2 (2014), 106-114.